Pharmacokinetic parameters explain the therapeutic activity of antimicrobial agents in a silkworm infection model

@article{Paudel2018PharmacokineticPE,
  title={Pharmacokinetic parameters explain the therapeutic activity of antimicrobial agents in a silkworm infection model},
  author={A. Paudel and Suresh Panthee and M. Urai and H. Hamamoto and T. Ohwada and K. Sekimizu},
  journal={Scientific Reports},
  year={2018},
  volume={8}
}
  • A. Paudel, Suresh Panthee, +3 authors K. Sekimizu
  • Published 2018
  • Chemistry, Medicine
  • Scientific Reports
    • Poor pharmacokinetic parameters are a major reason for the lack of therapeutic activity of some drug candidates. Determining the pharmacokinetic parameters of drug candidates at an early stage of development requires an inexpensive animal model with few associated ethical issues. In this study, we used the silkworm infection model to perform structure-activity relationship studies of an antimicrobial agent, GPI0039, a novel nitrofuran dichloro-benzyl ester, and successfully identified compound… CONTINUE READING
    View on Springer
    nature.com
    12 Citations
    Background Citations
    4
    12 Citations
    Citation Type

    Citation Type

    Model Organisms and Antimicrobial Drug Discovery
    A Silkworm Infection Model for In Vivo Study of Glycopeptide Antibiotics
    • PDF
    Facilitating Drug Discovery in Human Disease Models Using Insects.
    • 2
    Large-scale screening and identification of novel pathogenic Staphylococcus aureus genes using a silkworm infection model.
    • 4
    Uncovering Staphylococcus aureus genes with roles in pathogenicity by silkworm infection model
    • PDF
    A novel silkworm infection model with fluorescence imaging using transgenic Trichosporon asahii expressing eGFP
    • 1
    • PDF
    A simple artificial diet available for research of silkworm disease models.
    • 1
    • PDF
    Thinking Outside the Box-Novel Antibacterials To Tackle the Resistance Crisis.
    • 39
    Bacterial polysaccharides inhibit sucrose-induced hyperglycemia in silkworms.
    • 3
    • PDF
    Polysaccharides of a fermented food, natto, suppress sucrose-induced hyperglycemia in an in vivo evaluation system and inhibit glucose uptake by human intestinal cells.
    • PDF

    References

    SHOWING 1-10 OF 38 REFERENCES
    Advantages of the Silkworm As an Animal Model for Developing Novel Antimicrobial Agents
    • 34
    • PDF
    A Novel Spiro-Heterocyclic Compound Identified by the Silkworm Infection Model Inhibits Transcription in Staphylococcus aureus
    • 10
    • PDF
    Galleria mellonella as a model system to test the pharmacokinetics and efficacy of antibiotics against Burkholderia pseudomallei.
    • 48
    Silkworm as a model animal to evaluate drug candidate toxicity and metabolism.
    • 107
    Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection
    • 34
    Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
    • 110
    • PDF
    Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection.
    • 62
    Quantitative Evaluation of the Therapeutic Effects of Antibiotics Using Silkworms Infected with Human Pathogenic Microorganisms
    • 166
    • PDF
    Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations
    • 18
    • PDF
    Nosokomycins, new antibiotics discovered in an in vivo-mimic infection model using silkworm larvae. I: Fermentation, isolation and biological properties
    • 34
    • PDF